The Department of Defense is offering the FY19 MRP Team Science Award to support hypothesis-driven studies in melanoma research. This grant focuses on fostering multidisciplinary teams to address crucial knowledge gaps in melanoma research, emphasizing collaboration and unique skill sets among team members. Projects should align with the FY19 MRP Challenge Statement and Focus Areas, excluding late-stage disease models and clinical trials. The TSA allows for studies in animal models and human subjects, encouraging the use of relevant preclinical models. Applications must be submitted by Oct 23, 2019, 12:00:00 AM EDT.
Science and Technology and other Research and Development
Category Explanation:
–
Expected Number of Awards:
2
Assistance Listings:
12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Version:
Synopsis 1
Posted Date:
May 16, 2019
Last Updated Date:
May 16, 2019
Original Closing Date for Applications:
Oct 23, 2019
Current Closing Date for Applications:
Oct 23, 2019
Archive Date:
Nov 22, 2019
Estimated Total Program Funding:
$2,240,000
Award Ceiling:
–
Award Floor:
–
Eligibility
Eligible Applicants:
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
–
Additional Information
Agency Name:
Dept. of the Army — USAMRAA
Description:
The FY19 MRP Team Science Award (TSA) supports
hypothesis-driven studies across the entire spectrum of research to tackle the
overarching FY19 MRP Challenge Statement and FY19 MRP Focus Areas. The TSA is
intended to advance studies in melanoma through a multidisciplinary team, bringing
together divergent disciplines to foster a novel approach to melanoma research.
The TSA requires that investigators jointly design a single project. However,
each partner will be recognized as a Principal Investigator (PI), must submit a
separate application, and will be the named PI on an individual award. The
application must clearly define the synergistic components that will facilitate
and accelerate progress in melanoma in a way that could not be accomplished
through independent efforts. Each team member should offer unique skill sets
and offer different perspectives on the project. Research projects funded by
the TSA should address critical knowledge gaps with the FY19 MRP Challenge
Statement covering at least one of the required FY19 MRP Focus Areas. The
Team Science Award is not intended to study research into established
late-stage disease models or the clinical utility of PD-1 in combination with
other therapeutics. Studies involving non-melanoma skin cancers are not allowed
under the FY19 MRP. Funding for clinical trials is not allowed.
The TSA may support studies in animal models, human
subjects, and human anatomical substances. Accordingly, development or use of
relevant preclinical models may be included. The TSA is not intended to support
high-throughput screenings, sequencing, etc.
Link to Additional Information:
–
Grantor Contact Information:
If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org Email:help@eBRAP.org
Version History
Version
Modification Description
Updated Date
Related Documents
Folder 316046 Full Announcement-FY19 MRP TSA -> MRP_FY19_TSA_GG-dmk.pdf
Packages
Agency Contact Information:
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org
